Invention Grant
- Patent Title: Fused pyrimidines as inhibitors of p97 complex
-
Application No.: US15792514Application Date: 2017-10-24
-
Publication No.: US10174005B2Publication Date: 2019-01-08
- Inventor: Han-Jie Zhou , David Wustrow
- Applicant: Cleave Biosciences, Inc.
- Applicant Address: US CA Burlingame
- Assignee: Cleave Biosciences, Inc.
- Current Assignee: Cleave Biosciences, Inc.
- Current Assignee Address: US CA Burlingame
- Agency: Schwegman Lundberg & Woessner, P.A.
- Main IPC: C07D403/04
- IPC: C07D403/04 ; C07D471/04 ; C07D491/048 ; C07D491/052

Abstract:
The present invention is directed to certain fused pyrimidines having a homo or hetero cyclopentyl, cyclohexyl or cycloheptyl ring as the pyrimidine fusion partner; having an amino benzyl or substituted amino benzyl group at the 4 position of the pyrimidine ring; and a 5:6 heterobicyclo ring with at least one N, O or S at the 2 position of the pyrimidine ring. These compounds are useful for treatment of cancer by inhibition of the p97 complex.
Public/Granted literature
- US20180044325A1 FUSED PYRIMIDINES AS INHIBITORS OF P97 COMPLEX Public/Granted day:2018-02-15
Information query